Clinical Cell Culture renames
Tuesday, 10 June, 2008
Clinical Cell Culture (ASX: CCE) is to be re-named Avita Medical following a shareholder meeting.
The resolution to change the company's name was passed by the vast majority of shareholders.
Shareholders have also resolved to consolidate the company's shares on a 10:1 basis.
The company believes that a name change and the recent shake-up of the boardroom will help drive sales of the company's products, such as the ReCell autologous skin cell kit, further.
Novel antibiotic activates 'suicide' mechanism in superbug
Researchers have discovered a new class of antibiotic that selectively targets Neisseria...
Modifications in the placenta linked to psychiatric disorders
Schizophrenia, bipolar disorder and major depression disorder are the neuropsychiatric disorders...
ADHD may be linked with an increased risk of dementia
An adult brain affected by attention deficit hyperactivity disorder (ADHD) presents modifications...